Recent Patents on Anti-Cancer Drug Discovery This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Sema3A Inhibits Osteolytic Bone Metastasis of Non-small Cell Lung Cancer
CONCLUSION: This study provides a new idea for the clinical treatment of osteolytic bone metastasis in NSCLC.PMID:38629364 | DOI:10.2174/0115748928295263240402085411 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - April 17, 2024 Category: Cancer & Oncology Authors: Wei Wang Kaicheng Shen Ruyan Liu Qi Zhou Source Type: research

Eukaryotic Initiation Factor 3C Can Affect the Proliferation and Invasion of Ovarian Cancer by Regulating the p53 Signalling Pathway
CONCLUSION: There is a correlation between overexpression of EIF3C in tumour tissues of ovarian cancer patients and this is associated with a poorer prognosis. By influencing the p53 signaling pathway, EIF3C facilitates the growth and infiltration of cells in ovarian cancer.PMID:38629365 | DOI:10.2174/0115748928292248240401051408 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - April 17, 2024 Category: Cancer & Oncology Authors: Jingkaiwen Zhang Hanlin Yang Fang Wen Qing Li Hao Luo Dan Zi Source Type: research

Sema3A Inhibits Osteolytic Bone Metastasis of Non-small Cell Lung Cancer
CONCLUSION: This study provides a new idea for the clinical treatment of osteolytic bone metastasis in NSCLC.PMID:38629364 | DOI:10.2174/0115748928295263240402085411 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - April 17, 2024 Category: Cancer & Oncology Authors: Wei Wang Kaicheng Shen Ruyan Liu Qi Zhou Source Type: research

Eukaryotic Initiation Factor 3C Can Affect the Proliferation and Invasion of Ovarian Cancer by Regulating the p53 Signalling Pathway
CONCLUSION: There is a correlation between overexpression of EIF3C in tumour tissues of ovarian cancer patients and this is associated with a poorer prognosis. By influencing the p53 signaling pathway, EIF3C facilitates the growth and infiltration of cells in ovarian cancer.PMID:38629365 | DOI:10.2174/0115748928292248240401051408 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - April 17, 2024 Category: Cancer & Oncology Authors: Jingkaiwen Zhang Hanlin Yang Fang Wen Qing Li Hao Luo Dan Zi Source Type: research

Sema3A Inhibits Osteolytic Bone Metastasis of Non-small Cell Lung Cancer
CONCLUSION: This study provides a new idea for the clinical treatment of osteolytic bone metastasis in NSCLC.PMID:38629364 | DOI:10.2174/0115748928295263240402085411 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - April 17, 2024 Category: Cancer & Oncology Authors: Wei Wang Kaicheng Shen Ruyan Liu Qi Zhou Source Type: research

Eukaryotic Initiation Factor 3C Can Affect the Proliferation and Invasion of Ovarian Cancer by Regulating the p53 Signalling Pathway
CONCLUSION: There is a correlation between overexpression of EIF3C in tumour tissues of ovarian cancer patients and this is associated with a poorer prognosis. By influencing the p53 signaling pathway, EIF3C facilitates the growth and infiltration of cells in ovarian cancer.PMID:38629365 | DOI:10.2174/0115748928292248240401051408 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - April 17, 2024 Category: Cancer & Oncology Authors: Jingkaiwen Zhang Hanlin Yang Fang Wen Qing Li Hao Luo Dan Zi Source Type: research

Sema3A Inhibits Osteolytic Bone Metastasis of Non-small Cell Lung Cancer
CONCLUSION: This study provides a new idea for the clinical treatment of osteolytic bone metastasis in NSCLC.PMID:38629364 | DOI:10.2174/0115748928295263240402085411 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - April 17, 2024 Category: Cancer & Oncology Authors: Wei Wang Kaicheng Shen Ruyan Liu Qi Zhou Source Type: research

Eukaryotic Initiation Factor 3C Can Affect the Proliferation and Invasion of Ovarian Cancer by Regulating the p53 Signalling Pathway
CONCLUSION: There is a correlation between overexpression of EIF3C in tumour tissues of ovarian cancer patients and this is associated with a poorer prognosis. By influencing the p53 signaling pathway, EIF3C facilitates the growth and infiltration of cells in ovarian cancer.PMID:38629365 | DOI:10.2174/0115748928292248240401051408 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - April 17, 2024 Category: Cancer & Oncology Authors: Jingkaiwen Zhang Hanlin Yang Fang Wen Qing Li Hao Luo Dan Zi Source Type: research

Fat-soluble Vitamins and Lung Cancer: Where We Are?
Recent Pat Anticancer Drug Discov. 2024 Apr 3. doi: 10.2174/0115748928283728240320063619. Online ahead of print.ABSTRACTFat-soluble vitamins (vitamins A, D, E, and K) are vital substances for maintaining normal physiological functions in the body. In recent years, scholars have explored the relationship between fat-soluble vitamins and the wasting disease - lung cancer. In this paper, we review recent studies on fat-soluble vitamins and lung cancer to clarify the relevance and molecular mechanisms of various vitamins in lung cancer, and whether the levels of fat-soluble vitamins in the body and vitamin supplementation affe...
Source: Recent Patents on Anti-Cancer Drug Discovery - April 8, 2024 Category: Cancer & Oncology Authors: Xue Lin Yaxuan Wang Tongzuo Zhang Xiaoyan Pu Source Type: research